Страховка пари до ₽1500 от БК GGBet.ru

Промокод: BR1500

Get a bonus

Users' Choice

Arsenal Midfielder Emile Smith Rowe Ruled Out of Manchester City Clash with Thigh Injury

Israel Oluwaseg Lawal
Israel Oluwaseg Lawal
Arsenal will be without their English playmaker Emile Smith Rowe as the 22 years old is out of their FA Cup clash due to injury.

In a blow to Arsenal’s squad, young forward Emile Smith Rowe has suffered a setback in his recovery from injury and will not be available for the upcoming match against Manchester City. The 22-year-old has had a frustrating season thus far, limited to just seven substitute appearances across all competitions. Smith Rowe’s campaign was further hindered when he lost his starting spot to Gabriel Martinelli and was forced to undergo surgery for an aggravated groin injury in September.

Although he made his return to the pitch in a match against Oxford United earlier this month, Smith Rowe has now suffered a new injury, unrelated to his previous one.

The Evening Standard  reports that he has been left behind in London as a precautionary measure. The Gunners will also be without midfielder Mohamed Elneny, who is feared to be out for the rest of the season with a knee injury.

It remains to be seen how this will impact Arsenal manager Mikel Arteta’s lineup choices for the match against Manchester City, but he is well aware that he will be facing off against one of the strongest teams in the world, regardless of the opposition’s selection.

Still have questions? Ask our experts!
Comments
Follow this expert
Follow this author

You've successfully followed this author. You'll get notifications of his new tips on your registered e-mail.

You've successfully followed this expert. You'll get notifications of his new tips on your registered e-mail.

Follow this author
Follow this expert

This means that you will no longer receive notifications about new posts by this author to your e-mail address.

You will no longer be notified of this expert's new tips.

The website you are trying to access is not one of our trusted partners.
You will be forwarded to the website
Visit site